- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 15, 2026 | 11.96M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 12.35M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 11.45M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 654.42K sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 607.96K sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $2.32M |
| Capex | Q3 2026 · Mar 31, 2026 | $11K |
| Capex | Q3 2026 · Mar 31, 2025 | $8K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$16.24M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$11.03M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $74.45M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $15.04M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $75.23M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $73.41M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $77.01M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $13.39M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $7.4M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $964K |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $6.6M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $11.22M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $1.93M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $6.98M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $5.05M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $7.06M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $80.1M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $19.96M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $80.28M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $20.45M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.35 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$1.51 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$6.19 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$25.39 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.35 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$1.51 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$6.19 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$25.39 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $3.73M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $14.12M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $2.27M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $9.3M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $321K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $3.72M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $2.74M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $7.05M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$3.88M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$16.81M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$6.52M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$6.41M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$3.97M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$15.28M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$5.89M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$5.42M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$4.05M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$17.84M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$5M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$16.26M |